These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 10405675)
1. From aspartame to Xenical. A look at the FDA review process. Trissler RJ J Am Diet Assoc; 1999 Jul; 99(7):797-8. PubMed ID: 10405675 [No Abstract] [Full Text] [Related]
2. Structure/function claims in dietary supplement labeling: not all of these claims need to be submitted to FDA and accompanied in labeling by the DSHEA disclaimer. McNamara SH Food Drug Law J; 1999; 54(1):35-42. PubMed ID: 11758558 [No Abstract] [Full Text] [Related]
3. Agency information collection activities; announcement of OMB approval; Food Labeling: Nutrition Labeling of Dietary Supplements on a "Per Day" Basis. Food and Drug Administration, HHS. Notice. Fed Regist; 1999 Mar; 64(57):14451. PubMed ID: 10558410 [TBL] [Abstract][Full Text] [Related]
4. FDA regulation of ingredients in dietary supplements after passage of the Dietary Supplement Health and Education Act of 1994: an update. McNamara SH Food Drug Law J; 1996; 51(2):313-8. PubMed ID: 11822323 [No Abstract] [Full Text] [Related]
6. US Food and Drug Administration regulations governing label claims for food products, including probiotics. Saldanha LG Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715 [TBL] [Abstract][Full Text] [Related]
7. Keeping up with the increasing popularity of nonvitamin, nonmineral supplements. Hankin J J Am Diet Assoc; 2000 Apr; 100(4):419-20. PubMed ID: 10767896 [No Abstract] [Full Text] [Related]
8. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. Final rule. Food and Drug Administration, HHS Fed Regist; 2007 Jun; 72(121):34751-958. PubMed ID: 17674484 [TBL] [Abstract][Full Text] [Related]
9. FDA perspectives on supplement use by patients on antithrombotic therapy. Kim MJ Thromb Res; 2005; 117(1-2):197-200; discussion 201-7. PubMed ID: 16188297 [No Abstract] [Full Text] [Related]
10. FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview. Woo JJ Thromb Res; 2005; 117(1-2):193-6; discussion 201-7. PubMed ID: 16253311 [No Abstract] [Full Text] [Related]
11. Under the law, FDA must grant different standards for new dietary ingredients and food additives. Mister S; Hathcock J Regul Toxicol Pharmacol; 2012 Apr; 62(3):456-8. PubMed ID: 22310217 [TBL] [Abstract][Full Text] [Related]
12. FDA regulation of dietary supplements and requirements regarding adverse event reporting. Frankos VH; Street DA; O'Neill RK Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973 [TBL] [Abstract][Full Text] [Related]
13. Maintaining a level playing field: the need for a uniform standard to evaluate health claims for foods and dietary supplements. Pappas CD Food Drug Law J; 2002; 57(1):25-41. PubMed ID: 12118479 [No Abstract] [Full Text] [Related]
14. Food ingredient review at FDA: recent data and initiatives to improve the process. Rulis AM; Tarantino LM Regul Toxicol Pharmacol; 1996 Dec; 24(3):224-31. PubMed ID: 8975749 [No Abstract] [Full Text] [Related]
15. Inappropriate advertising of dietary supplements. de Lemos ML N Engl J Med; 2003 May; 348(22):2255-6; author reply 2255-6. PubMed ID: 12774807 [No Abstract] [Full Text] [Related]
16. Generally recognized as safe (GRAS): history and description. Burdock GA; Carabin IG Toxicol Lett; 2004 Apr; 150(1):3-18. PubMed ID: 15068820 [TBL] [Abstract][Full Text] [Related]
17. Regulating dietary supplement safety under the dietary supplement health and education act: brave new world or pyrrhic victory? Silverglade BA Food Drug Law J; 1996; 51(2):319-21. PubMed ID: 11822324 [No Abstract] [Full Text] [Related]
18. Food labeling update: FDA and USDA release proposed regulations. J Am Diet Assoc; 1991 Dec; 91(12):1514. PubMed ID: 1960339 [No Abstract] [Full Text] [Related]